This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

Event Date: 04/14/2020
Location: Teleconference
Subject: COVID-19 Update: Serological Tests
FDA Participant/Group: JEFFREY SHUREN; TIMOTHY STENZEL; KEAGAN LENIHAN; COLIN ROM; ANAND SHAH;
Non FDA Participant/Group: Several members of the Association of Public Health Laboratories Board and other invited guests

Event Date: 04/14/2020
Location: Teleconference
Subject: COVID-19 Response
FDA Participant/Group: ANAND SHAH; KEAGAN LENIHAN; JEFFREY SHUREN; COLIN ROM; TIMOTHY STENZEL;
Non FDA Participant/Group: Julie Khani (American Clinical Laboratory Association); Adam Schechter (LabCorp); Bill Morice (Mayo Clinic Laboratories); Sherrie Perkins (ARUP Laboratories); Stephen Rusckowski (Quest Diagnostics);

Event Date: 04/15/2020
Location: Teleconference
Subject: COVID-19
FDA Participant/Group: KEAGAN LENIHAN; JANET WOODCOCK;
Non FDA Participant/Group: Daniel O'Day (Gilead);

Event Date: 04/15/2020
Location: Teleconference
Subject: COVID-19 Update: Serological Tests
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the AdvaMedDx Board

Event Date: 04/16/2020
Location: Teleconference
Subject: COVID 19 Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from PhRMA (Pharmaceutical Research and Manufacturers of America) and BIO (Biotechnology Innovation Organization)

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 04/16/2020
Location: Virtual
Subject: COVID-19 Evidence Accelerator Lab Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, patient groups, and government

Event Date: 04/16/2020
Location: Virtual
Subject: Translational Science 2020; Speaker: A Conversation with FDA’s Principal Deputy Commissioner
FDA Participant/Group: N/A
Non FDA Participant/Group: Academics, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

Event Date: 04/15/2020
Location: Teleconference
Subject: COVID-19 Vaccine Development
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Jim Roquemore, Riley Polk, Thomas Wagner (Orbis Health);

Event Date: 04/15/2020
Location: Teleonference
Subject: COVID-19 Product Development
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Adrian Hepner, Michael Cordera (Eagle Pharmaceuticals); John Manthei (Latham and Watkins, LLC); Jeffrey J. Kimball (Jeffrey J. Kimball and Associates);

Event Date: 04/16/2020
Location: Webinar
Subject: COVID-19 Conference with North Dakota Health Care Providers; Hosted by SEN HOEVEN (R-ND)
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: North Dakota Health Care Stakeholders

Event Date: 04/17/2020
Location: Webinar
Subject: National Conference of State Legislatures Webinar; COVID-19: Therapies and Vaccines
FDA Participant/Group: ANAND SHAH;
Non FDA Participant/Group: Representatives from industry, government, and other stakeholders

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 04/14/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: NINA ZIMDAHL; CAITLIN BOON;
Non FDA Participant/Group: Several representatives from the food and beverage industry

Event Date: 04/15/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several members from the U.S. Senate Committee on Health, Education, Labor, and Pensions

Event Date: 04/15/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: MARK MOORMAN;
Non FDA Participant/Group: Several representatives from the National Restaurant Association

Event Date: 04/17/2020
Location: Virtual Meeting
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: KATHERINE SERRANO; MICHELLE RODRIGUEZ; DONALD PRATER;
Non FDA Participant/Group: Amada Velez Mendez, Javier Trujillo Arriaga, Jose Luis Lara (National Service for Animal and Plant Health, Food Safey and Quality, Government of Mexico);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event